ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02555306
Brief Title: A Phase I/II Safety, Tolerability, Immunogenicity, and Bioactivity Study of DE-122 Injectable Solution for Refractory Exudative Age-related Macular Degeneration

First Submitted : September 13, 2015
First Submitted that Met QC Criteria : September 17, 2015
First Posted : September 21, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : April 16, 2018
Last Update Posted : April 18, 2018